60 results
Page 3 of 3
8-K
EX-99.1
k84t65pg4 dj8t
10 Nov 21
Regulation FD Disclosure
7:12am
8-K
EX-99.1
gqaga dir79te2q7syw7
17 May 21
Regulation FD Disclosure
5:03pm
8-K
EX-99.1
87wg7
22 Apr 21
Yumanity Therapeutics’ YTX-7739 Achieved Target Engagement at Doses That Were Generally Well Tolerated
7:11am
8-K/A
EX-99.3
72ien6hfbipijo1jh
3 Feb 21
Other Events
4:59pm
8-K
EX-99.1
qzi39dsezyya8 jfofqc
7 Nov 19
Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-99.1
dxgpmwg
7 Jan 19
Departure of Directors or Certain Officers
7:31am
8-K
EX-99.1
sc9tuane5ewjd6ads
28 Nov 18
Regulation FD Disclosure
8:00am
8-K
EX-99.2
r2e pkxc8o058
17 Oct 18
Proteostasis Therapeutics Announces Positive Preliminary Results from
4:30pm
8-K
EX-99.2
vira v6rgbr9c1sz
6 Jun 18
Proteostasis Announces Positive Data from Ongoing Phase 1 Study ofPTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy
4:11pm
10-K
na6es4id1at8
30 Mar 16
Annual report
12:00am